Author Question: When selecting the site and placement of the pulse oximetry sensor, a nurse uses: A. The clip-on ... (Read 63 times)

sabina

  • Hero Member
  • *****
  • Posts: 563
When selecting the site and placement of the pulse oximetry sensor, a nurse uses:
 
  A. The clip-on probe for obese clients
  B. The fingers for hypothermic clients
  C. The earlobe for clients with tremors
  D. Disposable probes for clients with a latex allergy

Question 2

An electronic device that delivers a measured amount of intravenous fluid over a specified period (e.g., 100 mL/hr) using positive pressure is called an ___________________ .
 
  Fill in the blank(s) with correct word



Ksh22

  • Sr. Member
  • ****
  • Posts: 297
Answer to Question 1

C
C. If client has tremors or is likely to move, use earlobe.
A. If client is obese, clip-on probe may not fit properly; obtain a single use (tape-on) probe.
B. Peripheral vasoconstriction related to hypothermia can interfere with SpO2 determination.
D. If client has a latex sensitivity or latex allergy, avoid adhesive sensor that contains latex.

Answer to Question 2

electronic infusion device (EID)
An EID delivers a measured amount of fluid over a specified period (e.g., 100 mL/hr) using positive pressure. EIDs use an electronic sensor and an alarm that signals if the pressure in the system changes and the desired flow rate is altered.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

sabina

  • Hero Member
  • *****
  • Posts: 563
Both answers were spot on, thank you once again



Ksh22

  • Sr. Member
  • ****
  • Posts: 297

 

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library